In this regard, for insulin-resistant individuals with NAFLD, increases in both circulating glucose and insulin can be synergistic drivers of continuously elevated DNL, the hallmark of this disease18. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.